Table 2.

Univariate analysis on CR achievement

Variable
Criteria
% CR
P
Age   ≤ 30 y vs > 30 y   83 vs 63   .04  
Sex   M vs F   84 vs 52   .004  
Lymphadenopathy   + vs -   71 vs 94   .06  
Splenomegaly   + vs -   77 vs 77   NS  
Mediastinal mass   + vs -   74 vs 79   NS  
Hepatomegaly   + vs -   74 vs 76   NS  
WBC count   ≤ 50 × 109/L vs > 50 × 109/L   64 vs 87   .02  
Hb level   ≤ 100 g/L vs > 100 g/L   78 vs 74   NS  
Plt count   ≤ 100 × 109/L vs > 100 × 109/L   73 vs 78   NS  
FAB   L1 vs L2   82 vs 71   NS  
CD10   + vs -   82 vs 73   NS  
CD13 and/or CD33   + vs -   57 vs 80   .08  
CD34   + vs -   54 vs 84   .009  
Cytogenetic groups   Unsuccessful vs normal vs abnormal   83 vs 69 vs 66   NS  
CDKN2B and/or CDKN2A  + vs -   80 vs 73   NS  
MDR1 expression   + vs -   60 vs 83   .08  
MDR1 function
 		 + vs -
 		 46 vs 89
 		 .004
 
Variable
Criteria
% CR
P
Age   ≤ 30 y vs > 30 y   83 vs 63   .04  
Sex   M vs F   84 vs 52   .004  
Lymphadenopathy   + vs -   71 vs 94   .06  
Splenomegaly   + vs -   77 vs 77   NS  
Mediastinal mass   + vs -   74 vs 79   NS  
Hepatomegaly   + vs -   74 vs 76   NS  
WBC count   ≤ 50 × 109/L vs > 50 × 109/L   64 vs 87   .02  
Hb level   ≤ 100 g/L vs > 100 g/L   78 vs 74   NS  
Plt count   ≤ 100 × 109/L vs > 100 × 109/L   73 vs 78   NS  
FAB   L1 vs L2   82 vs 71   NS  
CD10   + vs -   82 vs 73   NS  
CD13 and/or CD33   + vs -   57 vs 80   .08  
CD34   + vs -   54 vs 84   .009  
Cytogenetic groups   Unsuccessful vs normal vs abnormal   83 vs 69 vs 66   NS  
CDKN2B and/or CDKN2A  + vs -   80 vs 73   NS  
MDR1 expression   + vs -   60 vs 83   .08  
MDR1 function
 		 + vs -
 		 46 vs 89
 		 .004
 

NS indicates not significant.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal